Stat3 has been found to be persistently activated in e.g., breast, prostate ovary and pancreatic tumors [87,88] and Stat5 in e.g., prostate and breast cancer [84,89], but also in various myeloproliferative diseases [28,37,39,90]. This evidence concerns the gene STAT3 and breast carcinoma.